期刊文献+

培菲康对实验性溃疡性结肠炎大鼠TNF-α、IL-10水平的影响 被引量:6

The effect of live combined bifidobacterium,lactobacillus and enterococcus on TNF-αand IL-10 level in experimental ulcerative colitis of rats
下载PDF
导出
摘要 目的阐明培菲康对三硝基苯磺酸钠(TNBS)诱导的大鼠溃疡性结肠炎(UC)TNF-α、IL-10水平的影响,寻求UC治疗的有效新途径。方法成年雌性SD大鼠50只,随机分成5组(n=10):正常对照组(G1)、模型对照组(G2)、培菲康治疗组(G3)、奥沙拉嗪治疗组(G4)、培菲康和奥沙拉嗪联合治疗组(G5),经不同处理和治疗后,通过免疫组化染色观测各组大鼠结肠组织中TNF-α(两步法)、IL-10(S-P法)表达情况,通过实时荧光定量PCR分析结肠组织中TNF-α、IL-10mRNA的表达水平。结果G1组各指标显著低于G2组(P<0.001),肠组织结构正常;与G2组相比,G3、G4、G5组TNF-α、IL-10细胞阳性率和TNF-α、IL-10mRNA的表达水平显著降低(P<0.001);与G3或G4组相比,G5组TNF-α、IL-10细胞阳性率和TNF-α、IL-10mRNA的表达水平也显著降低(P<0.001);G3或G4组之间,TNF-α、IL-10细胞阳性率及TNF-αmRNA水平无差别(P>0.05),而G4组IL-10mRNA水平明显低于G3组(P<0.001)。结论TNF-α、IL-10在溃疡性结肠炎(UC)的发生、发展过程中起重要作用,培菲康能明显降低该过程中肠组织TNF-α、IL-10的表达水平,可能通过调控这两个细胞因子的表达而发挥疗效。 Objective To investigate the effect of live combined bifidobacterium,lactobacillus and enterococcus capsules on ulcerative colitis(UC)in rats induced by trinitrobenzene sulfonic acid(TNBS),so as to explore a new and effective therapy for UC.Method Fifty female adult Sprague-Dawley rats were randomly divided into 5 groups(n=10),normal control group(G1),untreated TNBS-induced colitis group(G2),TNBS-induced colitis treated with live combined bifidobacterium,lactobacillus and enterococcus group(G3),TNBS-induced colitis treated with olsalazine group(G4)and TNBS-induced colitis treated with both live combined bifidobacterium,lactobacillus and enterococcus and olsalazine in the same dose and duration group(G5).Each group received different treatment as described above,and tumor necrosis factor-alpha(TNF-α),interleukin-10(IL-10)in colonic mucosa were observed through immunohistochemical stain(Two-step method for TNF-a,Streptavidin-Peroxidase method for IL-10)and analysized by multimedia pathological analysis system.Colonic mRNA levels of TNF-α and IL-10 were determined using real-time quantitative reverse transcriptase polymerase chain reaction(RT-PCR).Results Parameters of G1 were significantly lower than those of G2(P〈0.001);G3,G4 and G5 groups showed greater cellular positive rates of TNF-αand IL-10 and mRNA levels of TNF-αand IL-10(P〈0.001)when compared to G2;G5 showed more notable colonic TNF-αand IL-10 cellular positive rates and mRNA levels in comparison woth either G3 or G4(P〈0.001);Colonic cellular positive rates of TNF-αand IL-10 and TNF-αmRNA level were not significantly different between G3 and G4 group(P〉0.05),however,mRNA level of IL-10 in G4 was much lower than that in G3(P〈0.001).Conclusion TNF-αand IL-10 are both playing very important roles in the pathogenesis and development of ulcerative colitis.live combined bifidobacterium,lactobacillus and enterococcus can effectively downregulate the expressions of TNF-αand IL-10 in rats induced by TNBS,and its potential therapeutic effect may be modulating the expressions of these two cytokines.
出处 《现代消化及介入诊疗》 2010年第2期66-70,共5页 Modern Interventional Diagnosis and Treatment in Gastroenterology
关键词 溃疡性结肠炎 三硝基苯磺酸钠(TNBS) 培菲康 TNF-Α IL-10 Ulcerative colitis Trinitrobenzene sulfonic acid(TNBS) Live combined bifidobacterium lactobacillus and enterococcus Tumor necrosis factor-alpha(TNF-α) Interleukin-10(IL-10)
  • 相关文献

参考文献1

二级参考文献10

  • 1Balsari, A,Ceccarelli, A,Dubini, F,Fesce, E,Poli, G.The fecal microbial population in the irritable bowel syn-drome[].Microbiology.1982
  • 2Pimentel, M,Chow, E.J,Lin, H.C.Normalication of lactulose breath testing correlates with symptom im-provement in irritable bowel syndrome: a double-blind, randomized placebo-controlled study[].Am J Gastroen-terol.2003
  • 3Pimentel, M,Chow, E.J,Lin, H.C.Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome[].Am J Gastroenterol.2000
  • 4Drossman, D.A,Sandler, R.S,McKee, D.C,Lovitz, A.J.Bowel patterns among subjects not seeking health care. Use of a questionnaire to identify a population with bowel dysfunction[].Gastroenterology.1982
  • 5Nayak, A.K,Karnad, D.R,Abraham, P,Mistry, F.P.Metronidazole relieves symptoms in irritable bowel syn-drome: the confusion with so-called “chronic amebiasis”[].Indian J Gastroenterol.1997
  • 6O‘Mahony, L,McCarthy, J,Kelly, P,Hurley, G,Luo, F,Chen, K,O‘Sullivan, G.C,Kiely, B,Collins, J.K,Shanahan, F,Quigley, E.M.Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles[].Gastro-enterology.2005
  • 7Nobaek, S,Johansson, M.L,Molin, G,Ahrne, S,Jeppsson, B.Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome[].Am J Gastroenterol.2000
  • 8Brigidi, P,Vitali, B,Swennen, E,Bazzocchi, G,Matteuzzi, D.Effects of probiotic administration upon the composition and enzymatic activity of human fecal mi-crobiota in patients with irritable bowel syndrome or functional diarrhea[].Research in Microbiology.2001
  • 9Koide, A,Yamaguchi, T,Odaka, T,Koyama, H,Tsuyugu-chi, T,Kitahara, H,Ohto, M,Saisho, H.Quan-titative analysis of bowel gas using plain abdominal ra-diograph in patients with irritable bowel syndrome[].Am J Gastroenterol.2000
  • 10King, T.S,Elia, M.,Hunter, J.O.Abnormal colonic fermentation in irritable bowel syndrome[].Lancet.1998

共引文献32

同被引文献47

引证文献6

二级引证文献74

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部